Prospects for site-specific delivery of pharmacologic and molecular therapies
R Riessen
and
JM Isner
Department of Medicine (Cardiology), St. Elizabeth's Hospital, Tufts University School of Medicine, Boston, Massachusetts 02135.
The local delivery of therapeutic agents to the arterial wall represents a new strategy for the treatment of vascular diseases, including restenosis. Approaches for local, intravascular, site-specific delivery include 1) direct deposition of therapeutic agents into the vessel wall through an intravascular delivery system; 2) systemic administration of inactive agents followed by local activation; and 3) systemic administration of fusion toxins that have a specific affinity to proliferating smooth muscle cells at the angioplasty site. In addition to conventional drugs, new therapeutic agents based on molecular mechanisms, including recombinant genes and antisense oligonucleotides, are now under investigation. Although development of intravascular drug delivery devices, including those tailored to accommodate novel therapeutic agents, offers new treatment options for restenosis and other vascular diseases, certain issues that currently limit the safety and efficacy of these approaches remain to be addressed.
This article has been cited by other articles:

|
 |

|
 |
 
I. J. Sarembock
From Systemic Shotgun to Site-Specific Nanoparticle-Targeted Delivery: A New Paradigm for Drug Delivery
Arterioscler Thromb Vasc Biol,
November 1, 2008;
28(11):
1879 - 1881.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Herdeg, M. Oberhoff, A. Baumbach, S. Schroeder, M. Leitritz, A. Blattner, D. I Siegel-Axel, C. Meisner, and K. R Karsch
Effects of local all-trans-retinoic acid delivery on experimental atherosclerosis in the rabbit carotid artery
Cardiovasc Res,
February 1, 2003;
57(2):
544 - 553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Schoen and R. F. Padera Jr.
Cardiac Surgical Pathology
Card. Surg. Adult,
January 1, 2003;
2(2003):
119 - 185.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Kalinowski, H. Alfke, S. Bergen, K. J. Klose, J. J. Barry, and H.-J. Wagner
Comparative Trial of Local Pharmacotherapy with L-Arginine, r-Hirudin, and Molsidomine to Reduce Restenosis after Balloon Angioplasty of Stenotic Rabbit Iliac Arteries
Radiology,
June 1, 2001;
219(3):
716 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Kiesz, P. Buszman, J. L. Martin, E. Deutsch, M. M. Rozek, E. Gaszewska, M. Rewicki, P. Seweryniak, M. Kosmider, and M. Tendera
Local Delivery of Enoxaparin to Decrease Restenosis After Stenting: Results of Initial Multicenter Trial : Polish-American Local Lovenox NIR Assessment Study (The POLONIA Study)
Circulation,
January 2, 2001;
103(1):
26 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Baldwin, L. M. Wilson, I. Gradus-Pizlo, R. Wilensky, and K. March
Effect of Atherosclerosis on Transmural Convection and Arterial Ultrastructure : Implications for Local Intravascular Drug Delivery
Arterioscler Thromb Vasc Biol,
December 1, 1997;
17(12):
3365 - 3375.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. W. Liu, P. G. Anderson, J. F. Luo, and G. S. Roubin
Local Delivery of Ethanol Inhibits Intimal Hyperplasia in Pig Coronary Arteries After Balloon Injury
Circulation,
October 7, 1997;
96(7):
2295 - 2301.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. J Feldman and G. Steg
Optimal techniques for arterial gene transfer
Cardiovasc Res,
September 1, 1997;
35(3):
391 - 404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M Channon, G. J Fulton, J. L Gray, B. H Annex, G. A Shetty, M. A Blazing, K. G Peters, P.-O. Hagen, and S. E George
Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels
Cardiovasc Res,
September 1, 1997;
35(3):
505 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. I. Axel, W. Kunert, C. Goggelmann, M. Oberhoff, C. Herdeg, A. Kuttner, D. H. Wild, B. R. Brehm, R. Riessen, G. Koveker, et al.
Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery
Circulation,
July 15, 1997;
96(2):
636 - 645.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Perlman, L. Maillard, K. Krasinski, and K. Walsh
Evidence for the Rapid Onset of Apoptosis in Medial Smooth Muscle Cells After Balloon Injury
Circulation,
February 18, 1997;
95(4):
981 - 987.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Van Belle, F. O. Tio, T. Couffinhal, L. Maillard, J. Passeri, and J. M. Isner
Stent Endothelialization: Time Course, Impact of Local Catheter Delivery, Feasibility of Recombinant Protein Administration, and Response to Cytokine Expedition
Circulation,
January 21, 1997;
95(2):
438 - 448.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. K. Shah
New Antithrombotic Drugs for Coronary Artery Disease
Journal of Cardiovascular Pharmacology and Therapeutics,
April 1, 1996;
1(2):
165 - 176.
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Lovich and E. R. Edelman
Mechanisms of Transmural Heparin Transport in the Rat Abdominal Aorta After Local Vascular Delivery
Circ. Res.,
December 1, 1995;
77(6):
1143 - 1150.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Moura, J. Y.T. Lam, D. Hebert, J. R. Kermode, G. W. Grant, D. Robitaille, E. J. Klein, P. G. Yock, J. B. Simpson, and A. V. Kaplan
Intramural Delivery of Agent via a Novel Drug-Delivery Sleeve : Histological and Functional Evaluation
Circulation,
October 15, 1995;
92(8):
2299 - 2305.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M. Isner, K. Walsh, J. Symes, A. Pieczek, S. Takeshita, J. Lowry, S. Rossow, K. Rosenfield, L. Weir, E. Brogi, et al.
Arterial Gene Therapy for Therapeutic Angiogenesis in Patients With Peripheral Artery Disease
Circulation,
June 1, 1995;
91(11):
2687 - 2692.
[Full Text]
|
 |
|
|